Celsius Holdings (CELH) Stock Plunges 6% as Wall Street Analysts Advise Buying Opportunity

Celsius Holdings (CELH) stock declined 6% following news of a Texas investigation, yet major Wall Street analysts view the dip as a buying opportunity. Morgan Stanley upgraded the stock to Overweight with a $55 price target, while Bank of America maintained its Buy rating despite the regulatory scrutiny.

Celsius Holdings experienced a market pullback triggered by regulatory investigation news from Texas authorities, a development that typically creates short-term investor uncertainty. The 6% decline reflects immediate risk-aversion behavior, yet the response from major financial institutions suggests analysts perceive the weakness as temporary. Morgan Stanley's upgrade to Overweight status with a $55 target price signals confidence that current valuation does not reflect the company's fundamental value, implying the analyst expects the stock to recover and appreciate beyond current levels. Bank of America's maintained Buy rating reinforces this perspective, demonstrating institutional conviction despite headlines.

The disparity between market reaction and analyst positioning highlights a common pattern where short-term news creates opportunities for longer-term investors. Regulatory investigations, while material risks, do not necessarily impair underlying business fundamentals if the company can demonstrate compliance or resolve issues favorably. The timing of these analyst moves immediately following the stock decline suggests a deliberate contrarian stance, with Wall Street analysts viewing the Texas probe as a temporary headwind rather than a structural threat to operations or growth prospects.

For investors monitoring Celsius, the analyst upgrades and price targets provide technical reference points for potential entry strategies. The $55 Morgan Stanley target represents a meaningful upside target from depressed levels, attracting both value and momentum-oriented traders. The convergence of major bank support despite regulatory uncertainty typically precedes recovery phases, though outcomes depend on investigation resolution and company disclosures. Investors should monitor regulatory developments, quarterly earnings, and any statements addressing the Texas probe to assess whether analyst optimism proves justified.

• →Celsius stock fell 6% on Texas regulatory investigation news, creating a potential buying opportunity according to major analysts.
• →Morgan Stanley upgraded CELH to Overweight with a $55 price target immediately following the decline.
• →Bank of America maintained its Buy rating despite the investigation, signaling institutional confidence in long-term value.
• →The analyst upgrades suggest institutional investors view the regulatory headwind as temporary rather than structurally damaging.
• →Investors should monitor investigation developments and company disclosures to validate analyst optimism on recovery potential.